youtube_live
Q2 2027 earnings • in 3 days
See detailschevron_right
HINDUNILVR:NSE
Hindustan Unilever Ltd
₹1,814.70
arrow_downward
-0.74%(-13.60) 1D
Oct 23, 3:30:00 PM GMT+5:30 · INR
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HINDUNILVR...
Open
₹1,833.90
High
₹1,835.00
Low
₹1,781.10
Mkt. cap
4.27T
Avg. vol.
1.39M
Volume
1.19M
Dividend
2.26%
Quarterly dividend
₹10.25
Ex-dividend date
Jun 23, 2026
P/E ratio
28.51
52-wk high
₹2,633.68
52-wk low
₹1,781.10
EPS
₹63.65
Shares outstanding
2.22B
No. of employees
17K
Open
₹1,833.90
High
₹1,835.00
Low
₹1,781.10
Mkt. cap
4.27T
Avg. vol.
1.39M
Volume
1.19M
Dividend
2.26%
Quarterly dividend
₹10.25
Ex-dividend date
Jun 23, 2026
P/E ratio
28.51
52-wk high
₹2,633.68
52-wk low
₹1,781.10
EPS
₹63.65
Shares outstanding
2.22B
No. of employees
17K
News stories
From web sources and news partners
UA.NEWS
·
23 hours ago
Dow Jones falls 1.2% amid concerns over AI spending — The Rio Times
BigGo Finance
·
7 hours ago
Dow Plunges 652 Points After Crude Oil Tops $100 on Renewed US-Iran War Fears
Traders Union
·
9 hours ago
Phil Rosen: S&P 500 turned $10,000 into $54,839 from 2005 to 2025 if best days held
Profile
Hindustan Unilever Limited is an Indian fast-moving consumer goods company, headquartered in Mumbai. It is a subsidiary of the Anglo-Dutch company Unilever. Its products include foods, beverages, cleaning agents, personal care products and other consumer staples.
The company was established in India in 1931 as Hindustan Vanaspati Manufacturing Co. Following a merger of constituent groups in 1956, it was renamed Hindustan Lever Limited. The company was renamed again in June 2007 as Hindustan Unilever Limited.
Hindustan Unilever has been at the helm of a lot of controversies, such as dumping highly toxic mercury-contaminated waste in regular dumps, contaminating the land and water of Kodaikanal. The British-Dutch company also faced major flak for an advertising campaign covering the Hindu pilgrimage site at Kumbh Mela in a negative light, calling it a "place where old people get abandoned," a move that was termed racist and insensitive.
In December 2018 HUL announced its acquisition of GlaxoSmithKline India's consumer business for US$3.8 billion in an all-equity merger deal with a 1:4.39 ratio. Wikipedia
About Hindustan Unilever Ltd
Next call in 3 days
Wed, Oct 28, 12:30 PM
Fiscal period
Q2 2027
- Normalized EPS / Est. (INR)
- GAAP EPS / Est. (INR)
- / ₹21.84
Revenue / Est. (INR)
- / 173.16B
Fiscal Q2 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in INR | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 162.41B | 164.41B | 163.51B | 173.41B |
Cost of goods sold | 78.93B | 79.91B | 83.24B | 87.53B |
Cost of revenue | 78.93B | 79.91B | 83.24B | 87.53B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 24.11B | 24.36B | 23.93B | 24.26B |
Operating expense | 49.77B | 49.99B | 45.71B | 49.94B |
Total operating expenses | 128.70B | 129.90B | 128.95B | 137.47B |
Operating income | 33.71B | 34.51B | 34.56B | 35.94B |
Other non operating income | - | - | -380.00M | 1.88B |
EBT including unusual items | 35.70B | 29.19B | 39.24B | 36.32B |
EBT excluding unusual items | 33.86B | 34.95B | 34.78B | 37.07B |
Income tax expense | 8.76B | 8.01B | 9.22B | 9.52B |
Effective tax rate | 24.54% | 27.44% | 23.50% | 26.21% |
Other operating expenses | 22.08B | 22.26B | 18.30B | 22.15B |
Net income | 26.85B | 66.07B | 29.92B | 26.73B |
Net profit margin | 16.53% | 40.19% | 18.30% | 15.41% |
Earnings per share | 10.85 | 30.22 | 11.77 | 11.62 |
Interest and investment income | 1.47B | 1.39B | 640.00M | - |
Interest expense | -1.29B | -880.00M | - | -750.00M |
Net interest expenses | 180.00M | 510.00M | 640.00M | -750.00M |
Depreciation and amortization charges | 3.58B | 3.37B | 3.48B | 3.53B |
EBITDA | 37.34B | 36.57B | 36.74B | 38.12B |
Gain or loss from assets sale | - | - | - | - |